Bility is
an artificial limb
and Bio-robotics
Physical AI center
The opportunity
Significant weaknesses in current products
Current Artificial Limb products impose a set of difficulties, discomforts and lack of functionality and human awareness on their users
Growing global
demand
Higher rates of limb amputations due to the global diabetes surge and evolving conflicts and wars around the world highlight the growing need for much better artificial limbs than currently exist.
Harnessing Physical AI and advanced technologies
Rapid technological and scientifical advancements in various disciplines, such as Physical AI, materials science, robotics, and bio-technology, offer unprecedented opportunities to improve artificial limb and bio-robotic functionality, usability and comfort
Innovative Artificial Limbs Conceptual Model
We designed a ground-breaking conceptual model of next-generation artificial limbs, which meticulously defined the functions, principles of action and technology pathway to enable the development of superior next-generation artificial limbs. Our Conceptual model will direct and inspire our synergistic R&D effort.
Our unique Synergistic R&D framework interwinds internal core R&D and collaborative R&D with added valued partners, which together will reinforce and accelerate the development and commercialization of next-generation artificial limbs.
Internal
Core R&D
Conducted by four groups of developers, engineers and scientists focused on developing core bio-robotics technologies.
We will develop and monetize
the following Assets:
01
Human Locomotion Big Data
We will sell licenses to use our human locomotion big data, data generator and collaborative AI infrastructure to research institutes and commercial clients.
02
Bio-Robotics Operating System
We will implement an annual license fee model to monetize our proprietary Operating System, targeting related industries, market leaders and academic research groups.
03
Partnerships & Startups
Following our collaborations, we will partner as equity investors in related commercially attractive startups, providing seed investments and R&D Resources.
04
Proprietary and collaborative
intellectual properties
We will license our proprietary and collaborative technologies and IP to clients of interest in a broad spectrum of related industries.
The brains behind
Meet our leadership
Ido Merfeld, PhD
Founder & Chairman
Dr. Ido Merfeld, founder, holds a PhD in molecular biology with a specialty in neuroscience and a BA in computer science, economy and statistics. Dr. Merfeld co-founded and acted as CEO and chairman of Ivory Software Systems, a successful FinTech company based in Israel. Dr. Merfeld has also been involved in the establishment of several other startup companies and projects globally.
Yishay Falick, MD MBA
CEO
Dr. Yishay Falick is a physician-executive with extensive leadership across healthcare, government, and advanced technologies. He has served as Chairman of the Israeli Biochip Generic Technology Consortium, Director of HealthTech and Bioconvergence innovation at Israel Aerospace Industries, and CEO of a public hospital. An expert in ophthalmic stem cell reconstructive surgeries and licensed health systems management professional, he bridges clinical excellence with strategic innovation.
Erez Morag, PhD
VP Bio-mechanics
An accomplished innovation executive with over 20 years of leadership experience in human locomotion holding a PhD in Biomechanics. Expertise includes developing cutting-edge products, such as footwear and wearables, tailored for diverse populations ranging from youth to elite athletes.
Michal Fraifeld
VP Product Design
Design and Innovation Manager with a Master's (M.Des) and a Bachelor's in Industrial Design (B.Des) from Bezalel Academy of Art and Design.
The owner of a studio that specializes in design research and product design. Additionally, a senior lecturer in the Industrial Design Department at Shenkar College.